LEADER 03122nam 2200637Ia 450 001 9910792585903321 005 20230725023546.0 010 $a0-19-045353-2 010 $a1-282-61353-7 010 $a9786612613531 010 $a0-19-977438-2 035 $a(CKB)2670000000027958 035 $a(EBL)544487 035 $a(OCoLC)642685850 035 $a(SSID)ssj0000420036 035 $a(PQKBManifestationID)12154513 035 $a(PQKBTitleCode)TC0000420036 035 $a(PQKBWorkID)10385742 035 $a(PQKB)10467697 035 $a(MiAaPQ)EBC544487 035 $a(Au-PeEL)EBL544487 035 $a(CaPaEBR)ebr10394928 035 $a(CaONFJC)MIL261353 035 $a(EXLCZ)992670000000027958 100 $a20090604d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aHPV and other infectious agents in cancer$b[electronic resource] $eopportunities for prevention and public health /$fHans Krueger ... [et al.] 210 $aNew York $cOxford University Press$d2010 215 $a1 online resource (560 p.) 300 $aDescription based upon print version of record. 311 $a0-19-973291-4 320 $aIncludes bibliographical references and index. 327 $aContents; 1 Introduction-Infection and Cancer: An Expanding Paradigm; 2 Human Papillomavirus: Structure, Transmission, and Occurrence; 3 Human Papillomavirus: Infection, Natural History, and Carcinogenesis; 4 Human Papillomavirus: Associations with Cervical Cancer; 5 Human Papillomavirus: Associations with Noncervical Cancer; 6 Human Papillomavirus: Detection of Infection and Disease; 7 Human Papillomavirus: Prevention of Infection and Disease; 8 Hepatitis Viruses; 9 Helicobacter pylori; 10 Epstein-Barr Virus; 11 Human Herpesvirus Type 8; 12 Human T-cell Lymphotropic Virus Type 1 327 $a13 Conclusion-Infection and Cancer: A Paradigm ShiftIndex 330 $aAfter considering the aging population in developed countries, it has become clear to physicians and public policy administrators that prevention of cancer must play a more important role in national anti-cancer policy than it has in the past. The recent introduction of an HPV vaccine, coupled with discoveries concerning the relationship of H. pylori and cancer has brought the role of infectious agents in cancer into sharp focus in the medical community. While interest in the subject has grown, no single source existed to bring clinicians up-to-date on developments in disease mechanisms, popul 606 $aViral carcinogenesis 606 $aOncogenic viruses 606 $aPapillomaviruses 606 $aPapillomavirus diseases 615 0$aViral carcinogenesis. 615 0$aOncogenic viruses. 615 0$aPapillomaviruses. 615 0$aPapillomavirus diseases. 676 $a616.99/4071 701 $aKrueger$b Hans$01480620 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910792585903321 996 $aHPV and other infectious agents in cancer$93697331 997 $aUNINA